Eric Dube, Travere CEO
Former Shkreli company Travere lands licensing deal with Vifor on kidney drug
Just a month ago, the biotech formerly owned by convicted drug exec Martin Shkreli saw promising data related to its kidney drug sparsentan from …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
